Open access
Aug 2026
A compendium of next-generation patient-derived models for diverse cancers
The development of new therapeutics and the validation of pathogenetic cancer mechanisms require representative laboratory models1,2. However, existing collections represent only a fraction of the diversity observed in human cancer2, 3–4. Recent technologies have enabled efficient in vitro model derivation (for example...
Dina Elharouni, Mushriq Al-Jazrawe, Seongmin Choi et al.
· Nature · 3 citations